Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3073% above fair value
$61.72−0.25 (-0.40%)
Close on Nov 13, 2026Market cap $2.12BP/E 36.3Yield –
Ingevity ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Ingevity's ebitda for the twelve months ending Dec 31, 2024 was $534.20M, down 2.2% year over year. For fiscal 2025 it was $525.10M, down 1.7% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $561.40M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $525.10M | -1.7% |
| FY2024 | Dec 31, 2024 | $534.20M | -2.2% |
| FY2023 | Dec 31, 2023 | $546.00M | -2.7% |
| FY2022 | Dec 31, 2022 | $561.40M | +5.5% |
| FY2021 | Dec 31, 2021 | $532.10M | +6.8% |
| FY2020 | Dec 31, 2020 | $498.10M | +3.4% |
| FY2019 | Dec 31, 2019 | $481.90M | +27.7% |
| FY2018 | Dec 31, 2018 | $377.50M | +33.3% |
| FY2017 | Dec 31, 2017 | $283.10M | +39.9% |
| FY2016 | Dec 31, 2016 | $202.40M | +0.7% |
| FY2015 | Dec 31, 2015 | $200.90M | -18.2% |
| FY2014 | Dec 31, 2014 | $245.60M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $162.70M | +36.8% |
| Q3 FY2024 | Sep 30, 2024 | $136.40M | -3.3% |
| Q2 FY2024 | Jun 30, 2024 | $128.60M | -14.9% |
| Q1 FY2024 | Mar 31, 2024 | $106.50M | -21.1% |
| Q4 FY2023 | Dec 31, 2023 | $118.90M | +13.8% |
| Q3 FY2023 | Sep 30, 2023 | $141.00M | -14.0% |
| Q2 FY2023 | Jun 30, 2023 | $151.10M | +2.9% |
| Q1 FY2023 | Mar 31, 2023 | $135.00M | -7.6% |
| Q4 FY2022 | Dec 31, 2022 | $104.50M | -3.1% |
| Q3 FY2022 | Sep 30, 2022 | $163.90M | +11.4% |
| Q2 FY2022 | Jun 30, 2022 | $146.90M | +1.5% |
| Q1 FY2022 | Mar 31, 2022 | $146.10M | +10.3% |
| Q4 FY2021 | Dec 31, 2021 | $107.80M | -21.7% |
| Q3 FY2021 | Sep 30, 2021 | $147.10M | -3.7% |
| Q2 FY2021 | Jun 30, 2021 | $144.80M | +58.6% |
| Q1 FY2021 | Mar 31, 2021 | $132.40M | +13.6% |
| Q4 FY2020 | Dec 31, 2020 | $137.60M | +20.0% |
| Q3 FY2020 | Sep 30, 2020 | $152.70M | +12.7% |
| Q2 FY2020 | Jun 30, 2020 | $91.30M | -29.6% |
| Q1 FY2020 | Mar 31, 2020 | $116.50M | +14.2% |
| Q4 FY2019 | Dec 31, 2019 | $114.70M | +30.0% |
| Q3 FY2019 | Sep 30, 2019 | $135.50M | +28.6% |
| Q2 FY2019 | Jun 30, 2019 | $129.70M | +23.2% |
| Q1 FY2019 | Mar 31, 2019 | $102.00M | +29.8% |
| Q4 FY2018 | Dec 31, 2018 | $88.20M | -5.2% |
| Q3 FY2018 | Sep 30, 2018 | $105.40M | +45.0% |
| Q2 FY2018 | Jun 30, 2018 | $105.30M | +56.7% |
| Q1 FY2018 | Mar 31, 2018 | $78.60M | +56.6% |
| Q4 FY2017 | Dec 31, 2017 | $93.00M | +158.3% |
| Q3 FY2017 | Sep 30, 2017 | $72.70M | – |
| Q2 FY2017 | Jun 30, 2017 | $67.20M | – |
| Q1 FY2017 | Mar 31, 2017 | $50.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $36.00M | – |
See a number that looks wrong?